Taysha Gene Therapies's total assets for Q4 2025 were $343.32M, an increase of 8.46% from the previous quarter. TSHA total liabilities were $96.38M for the fiscal quarter, a -1.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.